Catalent CEO Alessandro Maselli said on Monday he will remain at the helm of the U.S.-based contract drugmaker after it is ...

Alessandro Maselli will remain president and CEO of Catalent (NYSE:CTLT) after its acquisition by Novo Holdings, according to ...

Catalent, a leading contract drug manufacturer, issued an open letter Monday to reassure customers that a proposed $16.5 ...

Novo expects to file for a label expansion for Rybelsus in the United States and the European Union around the turn of the ...

India's biggest group of retail distributors has asked the antitrust authority to investigate three quick commerce companies ...

Hospitals across India are often understaffed and doctors and nurses are overworked, resulting in small delays in patient ...

Pfizer suffered a blow earlier this month when new data showed that its gene therapy for Duchenne muscular dystrophy failed ...

"We are essentially moving from a situation of defeating the enemy in all the contact villages to a state of destruction." Information ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Heartseed Inc. and Novo Nordisk - in partnership since June 2021 - have announced that the first patient has been successfully dosed in a clinical study with HS-001, a cell therapy designed to ...

Provision of diversified services to the resources and infrastructure sectors in Australia, encompassing civil expertise including bulk earthworks and concrete installation, contract mining and ...